NCT04280081 2025-04-20LIBRETTO-321Eli Lilly and CompanyPhase 2 Active not recruiting77 enrolled 13 charts
NCT00019331 2013-06-20Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed